SpinePoint Medical Previews Low-Stiffness Cervical Interbody Cage

SpinePoint Medical is anticipating a 2025 launch for what it describes as the lowest stiffness interbody cages on the market.

SpinePoint expects its first FDA marketing clearance in mid-2024 for solutions to address implant failures and revision surgeries. The company’s proprietary technology is designed to produce the lowest stiffness cages...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us